DOI QR코드

DOI QR Code

A Case Report of a Patient with Advanced Non-Small Cell Lung Cancer Treated with Allergen Removed Rhus Verniciflua Stokes (aRVS)

알러젠 제거 옻나무 추출물 투여로 생존기간이 연장된 4기 비소세포성폐암 환자 1례

  • Choi, Seong-Heon (Dept. of Oriental constitutional Medicine, M.u integrative Cancer Center, Kyunghee University hospital at Gangdong) ;
  • Song, An-Na (Dept. of Oriental constitutional Medicine, M.u integrative Cancer Center, Kyunghee University hospital at Gangdong) ;
  • An, Ji-Hye (Dept. of Oriental constitutional Medicine, M.u integrative Cancer Center, Kyunghee University hospital at Gangdong) ;
  • Kim, Eun-Hee (Dept. of Oriental constitutional Medicine, M.u integrative Cancer Center, Kyunghee University hospital at Gangdong) ;
  • Park, So-Jeong (Dept. of Oriental constitutional Medicine, M.u integrative Cancer Center, Kyunghee University hospital at Gangdong) ;
  • Lee, Soo-Kyung (Kyunghee University, graduate school, Clinical oncology of Korean medicine) ;
  • Kim, Kyung-Suk (Dept. of Oriental constitutional Medicine, M.u integrative Cancer Center, Kyunghee University hospital at Gangdong)
  • 최성헌 (경희대학교 강동경희대학교병원 한방암센터) ;
  • 송안나 (경희대학교 강동경희대학교병원 한방암센터) ;
  • 안지혜 (경희대학교 강동경희대학교병원 한방암센터) ;
  • 김은희 (경희대학교 강동경희대학교병원 한방암센터) ;
  • 박소정 (경희대학교 강동경희대학교병원 한방암센터) ;
  • 이수경 (경희대학교 대학원 임상종양학과) ;
  • 김경석 (경희대학교 강동경희대학교병원 한방암센터)
  • Received : 2012.06.08
  • Accepted : 2012.06.25
  • Published : 2012.06.28

Abstract

Objective : We introduce a case of non-small cell lung cancer patient treated with allergen removed Rhus verniciflua Stokes. Methods : This patient started Allergen-removed Rhus Verniciflua Stokes from Feb 2010 right after his firstline chemotherapy, and maintained his Oriental medicine regimen until now. Results : It shows 12.0 months of progression-free-survival since starting point of maintenance chemotherapy, and 9.3 months of overall-survival since progression disease after 2nd chemotherapy, compared with 6.3 months of its known overall survival. Conclusion : Allergen removed Rhus verniciflua Stokes prolonged overall survival and slowed disease progression of a non-small cell lung cancer patient.

Keywords